AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
نویسندگان
چکیده
منابع مشابه
AF - 353 , a novel , potent and orally bioavailable P 2 X 3 / P 2 X 2 / 3 receptor antagonistbph
1Department of Inflammation Discovery, Roche Palo Alto, Palo Alto, CA, USA, 2Department of Metabolism and Pharmacokinetics, Roche Palo Alto, Palo Alto, CA, USA, 3Department of Neuroscience, Roche Palo Alto, Palo Alto, CA, USA, 4Department of Medicinal Chemistry, Roche Palo Alto, Palo Alto, CA, USA, 5Autonomic Neuroscience Centre, Royal Free and University College Medical School, London, UK, and...
متن کاملCTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
The metabotropic glutamate receptor 5 (mGlu5) is a glutamate-activated class C G protein-coupled receptor widely expressed in the central nervous system and clinically investigated as a drug target for a range of indications, including depression, Parkinson's disease, and fragile X syndrome. Here, we present the novel potent, selective, and orally bioavailable mGlu5 negative allosteric modulato...
متن کاملOrally bioavailable potent soluble epoxide hydrolase inhibitors.
A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane alpha to the urea were prepared and tested as soluble epoxide hydrolase (sEH) inhibitors. This series of compounds showed low nanomolar to picomolar activities against recombinant human sEH. Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human h...
متن کاملUNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrate...
متن کاملDesign and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist
A ligand-based virtual screening exercise examining likely bioactive conformations of AM 580 (2) and AGN 193836 (3) was used to identify the novel, less lipophilic RARα agonist 4-(3,5-dichloro-4-ethoxybenzamido)benzoic acid 5, which has good selectivity over the RARβ, and RARγ receptors. Analysis of the medicinal chemistry parameters of the 3,5-substituents of derivatives of template 5 enabled ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Pharmacology
سال: 2010
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.2010.00796.x